👨 Testosterone Therapy Fertility Impact Simulator
This simulator explores the impact of testosterone therapy on fertility. It examines how different dosages and treatment durations affect male and female reproductive health, offering insights into potential fertility outcomes.
Exogenous Testosterone Suppresses LH/FSH Output
Placeholder: external testosterone tricks the pituitary into slowing hormone release.
- Hypothalamus: Feedback sensed at (Placeholder short note)
- LH & FSH: Primary hormones cut (Placeholder short note)
- Weeks: Onset of suppression (Placeholder short note)
- Injection/gel: Common therapy route (Placeholder short note)
How exogenous testosterone signals the brain
Placeholder: circulating testosterone is read as a signal to reduce natural production.
Why fertility is affected early
Placeholder: LH and FSH normally drive testicular sperm production.
HPG Axis Negative Feedback Loop Shuts Down
Placeholder: the hypothalamic-pituitary-gonadal axis quiets its normal pulsatile signaling.
- Reduced: GnRH pulse amplitude (Placeholder short note)
- Near-zero: Pituitary LH output (Placeholder short note)
- Falls sharply: Intratesticular T (Placeholder short note)
- ~3 months: Time to full shutdown (Placeholder short note)
The feedback loop mechanics
Placeholder: high peripheral testosterone dampens GnRH pulsing upstream.
Consequence for local testicular hormone levels
Placeholder: intratesticular testosterone drops despite normal blood levels.
Spermatogenesis Declines, Raising Infertility Risk
Placeholder: sperm production slows as testicular stimulation disappears.
- 3–6 mo: Time to oligospermia (Placeholder short note)
- Up to ~90%: Azoospermia incidence (Placeholder short note)
- Decreases: Testicular volume (Placeholder short note)
- Progressive drop: Sperm count trend (Placeholder short note)
Testicular tissue changes over time
Placeholder: seminiferous tubules shrink without FSH/LH stimulation.
Clinical infertility implications
Placeholder: many men on therapy become temporarily infertile.
Reversibility Timeline After Stopping Therapy
Placeholder: fertility often recovers gradually once therapy is discontinued.
- ~4–12 mo: Median recovery time (Placeholder short note)
- Most patients: Full recovery cases (Placeholder short note)
- Longer duration: Factors slowing recovery (Placeholder short note)
- Uncommon: Rare permanent cases (Placeholder short note)
What drives recovery speed
Placeholder: duration of therapy and age influence recovery pace.
Monitoring recovery
Placeholder: semen analysis tracks the return of sperm production.
hCG and SERMs Help Preserve Fertility
Placeholder: co-therapies can keep testicular signaling active during treatment.
- LH activity: hCG mimics (Placeholder short note)
- Clomiphene/tamoxifen: SERM examples (Placeholder short note)
- Recommended: Sperm banking option (Placeholder short note)
- Before starting therapy: Counseling timing (Placeholder short note)
How hCG co-therapy works
Placeholder: hCG directly stimulates testicular Leydig cells like LH would.
Placeholder: discuss fertility goals with a clinician before starting therapy.
Alternative options for patients
Placeholder: SERMs and sperm banking are common preservation strategies.
This simulator explores the impact of testosterone therapy on fertility. It examines how different dosages and treatment durations affect male and female reproductive health, offering insights into potential fertility outcomes.
2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install